APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cough Lozenges

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cough Lozenges Market Outlook and Growth Opportunities 2026

23 December 2025200 pages

Choose your research edition.

Industry ResearchCough Lozenges Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Cough Lozenges Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Cough Lozenges Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cough Lozenges Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Cough Lozenges Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Cough Lozenges market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cough Lozenges is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cough Lozenges market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cough Lozenges market include Xi'an Keli Pharmaceutical, Sanofi, Novartis, Mylan, Jiuzhitang, Jiangxi Jianglai Health Technology, Pfizer, Hebei Bianque Pharmaceutical and Guizhou Kehui Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cough Lozenges market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cough Lozenges and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cough Lozenges sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cough Lozenges market size, projected growth trends, production technologies, key applications, and end-use industries.

Cough Lozenges Segment by Company

Xi'an Keli Pharmaceutical

Sanofi

Novartis

Mylan

Jiuzhitang

Jiangxi Jianglai Health Technology

Pfizer

Hebei Bianque Pharmaceutical

Guizhou Kehui Pharmaceutical

GlaxoSmithKline

Bayer

Amgen

AbbVie

AstraZeneca

Reckitt Benckiser

Procter And Gamble

Johnson And Johnson

Herbalife

Cigna

Boehringer Ingelheim

Cough Lozenges Segment by Type

Traditional Chinese Medicine Type

Biological Agent Type

Chemical Medicine Type

Compound Preparation Type

Cough Lozenges Segment by Application

Clinic

Hospital

Pharmacy

Retail Store

Others

Cough Lozenges Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cough Lozenges status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cough Lozenges market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cough Lozenges significant trends, drivers, influence factors in global and regions.

6. To analyze Cough Lozenges competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cough Lozenges market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cough Lozenges and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cough Lozenges.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cough Lozenges market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cough Lozenges industry.

Chapter 3: Detailed analysis of Cough Lozenges manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cough Lozenges in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cough Lozenges in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cough Lozenges Industry Trends Table 2. Cough Lozenges Industry Drivers Table 3. Cough Lozenges Industry Opportunities and Challenges Table 4. Cough Lozenges Industry Restraints Table 5. Global Cough Lozenges Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cough Lozenges Revenue Share by Company (2021-2026) Table 7. Global Cough Lozenges Sales Volume by Company (units) & (2021-2026) Table 8. Global Cough Lozenges Sales Volume Share by Company (2021-2026) Table 9. Global Cough Lozenges Average Price (USD/unit) of Company (2021-2026) Table 10. Global Cough Lozenges Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cough Lozenges Key Company Manufacturing Base & Headquarters Table 12. Global Cough Lozenges Company, Product Type & Application Table 13. Global Cough Lozenges Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cough Lozenges by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Traditional Chinese Medicine Type Table 18. Significant Companies of Biological Agent Type Table 19. Significant Companies of Chemical Medicine Type Table 20. Significant Companies of Compound Preparation Type Table 21. Global Cough Lozenges Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 22. Global Cough Lozenges Sales Volume by Type (2021-2026) & (units) Table 23. Global Cough Lozenges Sales Volume by Type (2027-2032) & (units) Table 24. Global Cough Lozenges Sales Volume Share by Type (2021-2026) Table 25. Global Cough Lozenges Sales Volume Share by Type (2027-2032) Table 26. Global Cough Lozenges Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cough Lozenges Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Cough Lozenges Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Cough Lozenges Sales Value Share by Type (2021-2026) Table 30. Global Cough Lozenges Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinic Table 32. Significant Companies of Hospital Table 33. Significant Companies of Pharmacy Table 34. Significant Companies of Retail Store Table 35. Significant Companies of Others Table 36. Global Cough Lozenges Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 37. Global Cough Lozenges Sales Volume by Application (2021-2026) & (units) Table 38. Global Cough Lozenges Sales Volume by Application (2027-2032) & (units) Table 39. Global Cough Lozenges Sales Volume Share by Application (2021-2026) Table 40. Global Cough Lozenges Sales Volume Share by Application (2027-2032) Table 41. Global Cough Lozenges Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Cough Lozenges Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Cough Lozenges Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Cough Lozenges Sales Value Share by Application (2021-2026) Table 45. Global Cough Lozenges Sales Value Share by Application (2027-2032) Table 46. Global Cough Lozenges Sales by Region: 2021 VS 2025 VS 2032 (units) Table 47. Global Cough Lozenges Sales by Region (2021-2026) & (units) Table 48. Global Cough Lozenges Sales Market Share by Region (2021-2026) Table 49. Global Cough Lozenges Sales by Region (2027-2032) & (units) Table 50. Global Cough Lozenges Sales Market Share by Region (2027-2032) Table 51. Global Cough Lozenges Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Cough Lozenges Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Cough Lozenges Sales Value Share by Region (2021-2026) Table 54. Global Cough Lozenges Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Cough Lozenges Sales Value Share by Region (2027-2032) Table 56. Global Cough Lozenges Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global Cough Lozenges Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global Cough Lozenges Sales by Country: 2021 VS 2025 VS 2032 (units) Table 59. Global Cough Lozenges Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Cough Lozenges Sales by Country (2021-2026) & (units) Table 61. Global Cough Lozenges Sales Market Share by Country (2021-2026) Table 62. Global Cough Lozenges Sales by Country (2027-2032) & (units) Table 63. Global Cough Lozenges Sales Market Share by Country (2027-2032) Table 64. Global Cough Lozenges Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Cough Lozenges Sales Value Market Share by Country (2021-2026) Table 66. Global Cough Lozenges Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Cough Lozenges Sales Value Market Share by Country (2027-2032) Table 68. Xi'an Keli Pharmaceutical Company Information Table 69. Xi'an Keli Pharmaceutical Business Overview Table 70. Xi'an Keli Pharmaceutical Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Xi'an Keli Pharmaceutical Cough Lozenges Product Portfolio Table 72. Xi'an Keli Pharmaceutical Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Sanofi Cough Lozenges Product Portfolio Table 77. Sanofi Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Novartis Cough Lozenges Product Portfolio Table 82. Novartis Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Mylan Cough Lozenges Product Portfolio Table 87. Mylan Recent Development Table 88. Jiuzhitang Company Information Table 89. Jiuzhitang Business Overview Table 90. Jiuzhitang Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Jiuzhitang Cough Lozenges Product Portfolio Table 92. Jiuzhitang Recent Development Table 93. Jiangxi Jianglai Health Technology Company Information Table 94. Jiangxi Jianglai Health Technology Business Overview Table 95. Jiangxi Jianglai Health Technology Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Jiangxi Jianglai Health Technology Cough Lozenges Product Portfolio Table 97. Jiangxi Jianglai Health Technology Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Pfizer Cough Lozenges Product Portfolio Table 102. Pfizer Recent Development Table 103. Hebei Bianque Pharmaceutical Company Information Table 104. Hebei Bianque Pharmaceutical Business Overview Table 105. Hebei Bianque Pharmaceutical Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Hebei Bianque Pharmaceutical Cough Lozenges Product Portfolio Table 107. Hebei Bianque Pharmaceutical Recent Development Table 108. Guizhou Kehui Pharmaceutical Company Information Table 109. Guizhou Kehui Pharmaceutical Business Overview Table 110. Guizhou Kehui Pharmaceutical Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Guizhou Kehui Pharmaceutical Cough Lozenges Product Portfolio Table 112. Guizhou Kehui Pharmaceutical Recent Development Table 113. GlaxoSmithKline Company Information Table 114. GlaxoSmithKline Business Overview Table 115. GlaxoSmithKline Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. GlaxoSmithKline Cough Lozenges Product Portfolio Table 117. GlaxoSmithKline Recent Development Table 118. Bayer Company Information Table 119. Bayer Business Overview Table 120. Bayer Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Bayer Cough Lozenges Product Portfolio Table 122. Bayer Recent Development Table 123. Amgen Company Information Table 124. Amgen Business Overview Table 125. Amgen Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Amgen Cough Lozenges Product Portfolio Table 127. Amgen Recent Development Table 128. AbbVie Company Information Table 129. AbbVie Business Overview Table 130. AbbVie Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. AbbVie Cough Lozenges Product Portfolio Table 132. AbbVie Recent Development Table 133. AstraZeneca Company Information Table 134. AstraZeneca Business Overview Table 135. AstraZeneca Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. AstraZeneca Cough Lozenges Product Portfolio Table 137. AstraZeneca Recent Development Table 138. Reckitt Benckiser Company Information Table 139. Reckitt Benckiser Business Overview Table 140. Reckitt Benckiser Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Reckitt Benckiser Cough Lozenges Product Portfolio Table 142. Reckitt Benckiser Recent Development Table 143. Procter And Gamble Company Information Table 144. Procter And Gamble Business Overview Table 145. Procter And Gamble Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Procter And Gamble Cough Lozenges Product Portfolio Table 147. Procter And Gamble Recent Development Table 148. Johnson And Johnson Company Information Table 149. Johnson And Johnson Business Overview Table 150. Johnson And Johnson Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Johnson And Johnson Cough Lozenges Product Portfolio Table 152. Johnson And Johnson Recent Development Table 153. Herbalife Company Information Table 154. Herbalife Business Overview Table 155. Herbalife Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Herbalife Cough Lozenges Product Portfolio Table 157. Herbalife Recent Development Table 158. Cigna Company Information Table 159. Cigna Business Overview Table 160. Cigna Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Cigna Cough Lozenges Product Portfolio Table 162. Cigna Recent Development Table 163. Boehringer Ingelheim Company Information Table 164. Boehringer Ingelheim Business Overview Table 165. Boehringer Ingelheim Cough Lozenges Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. Boehringer Ingelheim Cough Lozenges Product Portfolio Table 167. Boehringer Ingelheim Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Cough Lozenges Distributors List Table 171. Cough Lozenges Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Cough Lozenges Product Image Figure 2. Global Cough Lozenges Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cough Lozenges Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cough Lozenges Sales (2021-2032) & (units) Figure 5. Global Cough Lozenges Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Cough Lozenges Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Traditional Chinese Medicine Type Image Figure 10. Biological Agent Type Image Figure 11. Chemical Medicine Type Image Figure 12. Compound Preparation Type Image Figure 13. Global Cough Lozenges Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 14. Global Cough Lozenges Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Cough Lozenges Sales Volume Share by Type (2021-2032) Figure 16. Global Cough Lozenges Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cough Lozenges Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cough Lozenges Sales Value Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Pharmacy Image Figure 22. Retail Store Image Figure 23. Others Image Figure 24. Global Cough Lozenges Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 25. Global Cough Lozenges Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Cough Lozenges Sales Volume Share by Application (2021-2032) Figure 27. Global Cough Lozenges Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Cough Lozenges Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Cough Lozenges Sales Value Share by Application (2021-2032) Figure 30. Global Cough Lozenges Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 31. Global Cough Lozenges Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Cough Lozenges Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Cough Lozenges Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Cough Lozenges Sales Value (2021-2032) & (US$ Million) Figure 35. North America Cough Lozenges Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Cough Lozenges Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Cough Lozenges Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Cough Lozenges Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Cough Lozenges Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Cough Lozenges Sales Value (2021-2032) & (US$ Million) Figure 41. South America Cough Lozenges Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Cough Lozenges Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Cough Lozenges Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Cough Lozenges Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Cough Lozenges Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Cough Lozenges Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Cough Lozenges Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Cough Lozenges Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Chinese Medicine Type
  • Biological Agent Type
  • Chemical Medicine Type
  • Compound Preparation Type
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Retail Store
  • Others
Companies covered
  • Xi'an Keli Pharmaceutical
  • Sanofi
  • Novartis
  • Mylan
  • Jiuzhitang
  • Jiangxi Jianglai Health Technology
  • Pfizer
  • Hebei Bianque Pharmaceutical
  • Guizhou Kehui Pharmaceutical
  • GlaxoSmithKline
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Reckitt Benckiser
  • Procter And Gamble
  • Johnson And Johnson
  • Herbalife
  • Cigna
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cough Lozenges Sales Value (2021-2032)
  4. 1.2.2 Global Cough Lozenges Sales Volume (2021-2032)
  5. 1.2.3 Global Cough Lozenges Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cough Lozenges Market Dynamics
  1. 2.1 Cough Lozenges Industry Trends
  2. 2.2 Cough Lozenges Industry Drivers
  3. 2.3 Cough Lozenges Industry Opportunities and Challenges
  4. 2.4 Cough Lozenges Industry Restraints
3 Cough Lozenges Market by Company
  1. 3.1 Global Cough Lozenges Company Revenue Ranking in 2025
  2. 3.2 Global Cough Lozenges Revenue by Company (2021-2026)
  3. 3.3 Global Cough Lozenges Sales Volume by Company (2021-2026)
  4. 3.4 Global Cough Lozenges Average Price by Company (2021-2026)
  5. 3.5 Global Cough Lozenges Company Ranking (2024-2026)
  6. 3.6 Global Cough Lozenges Company Manufacturing Base and Headquarters
  7. 3.7 Global Cough Lozenges Company Product Type and Application
  8. 3.8 Global Cough Lozenges Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cough Lozenges Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cough Lozenges Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cough Lozenges Market by Type
  1. 4.1 Cough Lozenges Type Introduction
  2. 4.1.1 Traditional Chinese Medicine Type
  3. 4.1.2 Biological Agent Type
  4. 4.1.3 Chemical Medicine Type
  5. 4.1.4 Compound Preparation Type
  6. 4.2 Global Cough Lozenges Sales Volume by Type
  7. 4.2.1 Global Cough Lozenges Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cough Lozenges Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Cough Lozenges Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Cough Lozenges Sales Value by Type
  11. 4.3.1 Global Cough Lozenges Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cough Lozenges Sales Value by Type (2021-2032)
  13. 4.3.3 Global Cough Lozenges Sales Value Share by Type (2021-2032)
5 Cough Lozenges Market by Application
  1. 5.1 Cough Lozenges Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Retail Store
  6. 5.1.5 Others
  7. 5.2 Global Cough Lozenges Sales Volume by Application
  8. 5.2.1 Global Cough Lozenges Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cough Lozenges Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Cough Lozenges Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Cough Lozenges Sales Value by Application
  12. 5.3.1 Global Cough Lozenges Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cough Lozenges Sales Value by Application (2021-2032)
  14. 5.3.3 Global Cough Lozenges Sales Value Share by Application (2021-2032)
6 Cough Lozenges Regional Sales and Value Analysis
  1. 6.1 Global Cough Lozenges Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cough Lozenges Sales by Region (2021-2032)
  3. 6.2.1 Global Cough Lozenges Sales by Region: 2021-2026
  4. 6.2.2 Global Cough Lozenges Sales by Region (2027-2032)
  5. 6.3 Global Cough Lozenges Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cough Lozenges Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cough Lozenges Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cough Lozenges Sales Value by Region (2027-2032)
  9. 6.5 Global Cough Lozenges Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cough Lozenges Sales Value (2021-2032)
  12. 6.6.2 North America Cough Lozenges Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cough Lozenges Sales Value (2021-2032)
  15. 6.7.2 Europe Cough Lozenges Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cough Lozenges Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cough Lozenges Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cough Lozenges Sales Value (2021-2032)
  21. 6.9.2 South America Cough Lozenges Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cough Lozenges Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cough Lozenges Sales Value Share by Country, 2025 VS 2032
7 Cough Lozenges Country-level Sales and Value Analysis
  1. 7.1 Global Cough Lozenges Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cough Lozenges Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cough Lozenges Sales by Country (2021-2032)
  4. 7.3.1 Global Cough Lozenges Sales by Country (2021-2026)
  5. 7.3.2 Global Cough Lozenges Sales by Country (2027-2032)
  6. 7.4 Global Cough Lozenges Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cough Lozenges Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cough Lozenges Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cough Lozenges Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cough Lozenges Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cough Lozenges Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cough Lozenges Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cough Lozenges Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cough Lozenges Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cough Lozenges Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cough Lozenges Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cough Lozenges Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cough Lozenges Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cough Lozenges Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cough Lozenges Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cough Lozenges Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cough Lozenges Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cough Lozenges Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cough Lozenges Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cough Lozenges Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cough Lozenges Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cough Lozenges Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cough Lozenges Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cough Lozenges Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cough Lozenges Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cough Lozenges Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cough Lozenges Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cough Lozenges Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cough Lozenges Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cough Lozenges Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cough Lozenges Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cough Lozenges Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cough Lozenges Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cough Lozenges Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xi'an Keli Pharmaceutical
  2. 8.1.1 Xi'an Keli Pharmaceutical Company Information
  3. 8.1.2 Xi'an Keli Pharmaceutical Business Overview
  4. 8.1.3 Xi'an Keli Pharmaceutical Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xi'an Keli Pharmaceutical Cough Lozenges Product Portfolio
  6. 8.1.5 Xi'an Keli Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Cough Lozenges Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Cough Lozenges Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Cough Lozenges Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Jiuzhitang
  26. 8.5.1 Jiuzhitang Company Information
  27. 8.5.2 Jiuzhitang Business Overview
  28. 8.5.3 Jiuzhitang Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiuzhitang Cough Lozenges Product Portfolio
  30. 8.5.5 Jiuzhitang Recent Developments
  31. 8.6 Jiangxi Jianglai Health Technology
  32. 8.6.1 Jiangxi Jianglai Health Technology Company Information
  33. 8.6.2 Jiangxi Jianglai Health Technology Business Overview
  34. 8.6.3 Jiangxi Jianglai Health Technology Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Jianglai Health Technology Cough Lozenges Product Portfolio
  36. 8.6.5 Jiangxi Jianglai Health Technology Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Cough Lozenges Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Hebei Bianque Pharmaceutical
  44. 8.8.1 Hebei Bianque Pharmaceutical Company Information
  45. 8.8.2 Hebei Bianque Pharmaceutical Business Overview
  46. 8.8.3 Hebei Bianque Pharmaceutical Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hebei Bianque Pharmaceutical Cough Lozenges Product Portfolio
  48. 8.8.5 Hebei Bianque Pharmaceutical Recent Developments
  49. 8.9 Guizhou Kehui Pharmaceutical
  50. 8.9.1 Guizhou Kehui Pharmaceutical Company Information
  51. 8.9.2 Guizhou Kehui Pharmaceutical Business Overview
  52. 8.9.3 Guizhou Kehui Pharmaceutical Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guizhou Kehui Pharmaceutical Cough Lozenges Product Portfolio
  54. 8.9.5 Guizhou Kehui Pharmaceutical Recent Developments
  55. 8.10 GlaxoSmithKline
  56. 8.10.1 GlaxoSmithKline Company Information
  57. 8.10.2 GlaxoSmithKline Business Overview
  58. 8.10.3 GlaxoSmithKline Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline Cough Lozenges Product Portfolio
  60. 8.10.5 GlaxoSmithKline Recent Developments
  61. 8.11 Bayer
  62. 8.11.1 Bayer Company Information
  63. 8.11.2 Bayer Business Overview
  64. 8.11.3 Bayer Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Bayer Cough Lozenges Product Portfolio
  66. 8.11.5 Bayer Recent Developments
  67. 8.12 Amgen
  68. 8.12.1 Amgen Company Information
  69. 8.12.2 Amgen Business Overview
  70. 8.12.3 Amgen Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Amgen Cough Lozenges Product Portfolio
  72. 8.12.5 Amgen Recent Developments
  73. 8.13 AbbVie
  74. 8.13.1 AbbVie Company Information
  75. 8.13.2 AbbVie Business Overview
  76. 8.13.3 AbbVie Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AbbVie Cough Lozenges Product Portfolio
  78. 8.13.5 AbbVie Recent Developments
  79. 8.14 AstraZeneca
  80. 8.14.1 AstraZeneca Company Information
  81. 8.14.2 AstraZeneca Business Overview
  82. 8.14.3 AstraZeneca Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AstraZeneca Cough Lozenges Product Portfolio
  84. 8.14.5 AstraZeneca Recent Developments
  85. 8.15 Reckitt Benckiser
  86. 8.15.1 Reckitt Benckiser Company Information
  87. 8.15.2 Reckitt Benckiser Business Overview
  88. 8.15.3 Reckitt Benckiser Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Reckitt Benckiser Cough Lozenges Product Portfolio
  90. 8.15.5 Reckitt Benckiser Recent Developments
  91. 8.16 Procter And Gamble
  92. 8.16.1 Procter And Gamble Company Information
  93. 8.16.2 Procter And Gamble Business Overview
  94. 8.16.3 Procter And Gamble Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Procter And Gamble Cough Lozenges Product Portfolio
  96. 8.16.5 Procter And Gamble Recent Developments
  97. 8.17 Johnson And Johnson
  98. 8.17.1 Johnson And Johnson Company Information
  99. 8.17.2 Johnson And Johnson Business Overview
  100. 8.17.3 Johnson And Johnson Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Johnson And Johnson Cough Lozenges Product Portfolio
  102. 8.17.5 Johnson And Johnson Recent Developments
  103. 8.18 Herbalife
  104. 8.18.1 Herbalife Company Information
  105. 8.18.2 Herbalife Business Overview
  106. 8.18.3 Herbalife Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Herbalife Cough Lozenges Product Portfolio
  108. 8.18.5 Herbalife Recent Developments
  109. 8.19 Cigna
  110. 8.19.1 Cigna Company Information
  111. 8.19.2 Cigna Business Overview
  112. 8.19.3 Cigna Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Cigna Cough Lozenges Product Portfolio
  114. 8.19.5 Cigna Recent Developments
  115. 8.20 Boehringer Ingelheim
  116. 8.20.1 Boehringer Ingelheim Company Information
  117. 8.20.2 Boehringer Ingelheim Business Overview
  118. 8.20.3 Boehringer Ingelheim Cough Lozenges Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Boehringer Ingelheim Cough Lozenges Product Portfolio
  120. 8.20.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cough Lozenges Value Chain Analysis
  2. 9.1.1 Cough Lozenges Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cough Lozenges Sales Mode & Process
  6. 9.2 Cough Lozenges Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cough Lozenges Distributors
  9. 9.2.3 Cough Lozenges Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst